US Broker Ratings

Embecta Corp. (EMBC) Stock Analysis: Exploring the 87.90% Potential Upside for Savvy Investors

As investors seek promising opportunities in the healthcare sector, Embecta Corp. (NASDAQ: EMBC) stands out with a compelling potential upside of 87.90%. Embecta, a New Jersey-based medical device company, has..

Orthofix Medical Inc. (OFIX): Investor Outlook Reveals 46% Potential Upside Amidst Undervalued Metrics

Orthofix Medical Inc. (NASDAQ: OFIX), a notable player in the healthcare sector, specifically within the medical devices industry, is drawing attention with a compelling potential upside of 46.31%. This analysis..

AMN Healthcare Services Inc (AMN) Stock Analysis: Unlocking 13.45% Potential Upside in the Healthcare Staffing Sector

AMN Healthcare Services Inc (NASDAQ: AMN) is a compelling player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Dallas, Texas, AMN is renowned for its..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: A Biotech Contender with 88.51% Potential Upside

ArriVent BioPharma, Inc. (AVBP), a clinical-stage biopharmaceutical company from Newtown Square, Pennsylvania, is carving a niche in the biotechnology sector with its innovative approach to cancer treatment. Specializing in the..

Valneva SE (VALN) Stock Analysis: Unpacking a 111.63% Potential Upside in the Biotech Sector

Valneva SE (NASDAQ: VALN), a French biotechnology company specializing in vaccine development, is making waves in the healthcare sector with a tantalizing potential upside of 111.63%. As of the latest..

Eton Pharmaceuticals, Inc. (ETON) Stock Analysis: A 67.73% Potential Upside Beckons Investors in Rare Disease Therapeutics

Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a niche player in the healthcare sector, is capturing the attention of investors with its robust portfolio of treatments targeting rare diseases. Based in Deer..

Akebia Therapeutics, Inc. (AKBA) Stock Analysis: Uncovering a 216.55% Potential Upside in Healthcare

Investors searching for dynamic opportunities in the healthcare sector may find Akebia Therapeutics, Inc. (NASDAQ: AKBA) an intriguing candidate. With a market capitalization of $372.35 million and a focus on..

Inventiva S.A. (IVA) Stock Analysis: 151% Upside Potential Makes This Biotech a Hot Prospect

Inventiva S.A. (NASDAQ: IVA), a burgeoning name in the biotechnology sector, is capturing the attention of investors with its promising pipeline and substantial upside potential. Headquartered in Daix, France, this..

Maze Therapeutics, Inc. (MAZE)

⚠️ No article content returned.

..

EyePoint, Inc. (EYPT) Investor Outlook: Examining a 186.5% Potential Upside in the Biotech Sector

EyePoint, Inc. (NASDAQ: EYPT) captures investor attention with a remarkable potential upside of 186.5%, as analysts remain bullish on the company’s innovative approach in the biotechnology sector. Focusing on retinal..

Delcath Systems, Inc. (DCTH) Investor Outlook: Exploring a 133% Potential Upside in Healthcare Innovation

Delcath Systems, Inc. (NASDAQ: DCTH) is capturing investor interest with a compelling growth narrative centered around its innovative approach in the healthcare sector. Specializing in medical devices, Delcath is at..

LifeMD, Inc. (LFMD) Stock Analysis: A 150% Upside Potential Awaits Investors

LifeMD, Inc. (LFMD), operating within the healthcare sector as a health information services provider, is garnering significant attention from investors with its potential for substantial upside. Based in the United..

Definitive Healthcare Corp. (DH) Stock Analysis: Exploring the 154% Potential Upside for Investors

Definitive Healthcare Corp. (NASDAQ: DH) is capturing investor attention with its remarkable potential upside of 154.01%, as highlighted by recent analyst ratings. The company, a key player in the healthcare..

Sonida Senior Living, Inc. (SNDA) Stock Analysis: Navigating Revenue Growth Amidst Challenging Valuation Metrics

Sonida Senior Living, Inc. (SNDA), a key player in the healthcare sector, specializing in medical care facilities, presents a mixed bag for potential investors. With a market capitalization of $1.49..

Claritev Corporation (CTEV) Stock Analysis: Unpacking the 168% Potential Upside

Investors eyeing opportunities in the healthcare sector should take a closer look at Claritev Corporation (NASDAQ: CTEV). Despite its current challenges, the company’s potential upside of 168.19% makes it an..

GH Research PLC (GHRS) Stock Analysis: Potential 178% Upside Ignites Investor Interest

In the rapidly evolving world of biotechnology, GH Research PLC (NASDAQ: GHRS) stands out as a company with significant potential upside. Based in Dublin, Ireland, GH Research is a clinical-stage..

Immunome, Inc. (IMNM) Stock Analysis: A Biotech Bet with a Potential 74% Upside

Immunome, Inc. (NASDAQ: IMNM) is making waves in the biotechnology sector, capturing investor attention with its promising pipeline and a significant potential upside. As the healthcare landscape evolves, Immunome stands..

Keros Therapeutics (KROS) Investor Outlook: Exploring a Compelling 103.71% Potential Upside

Keros Therapeutics, Inc. (NASDAQ: KROS) is standing at an intriguing juncture for investors, with a compelling potential upside of 103.71%. The biopharmaceutical company, headquartered in Lexington, Massachusetts, specializes in developing..

Avadel Pharmaceuticals (AVDL) Stock Analysis: A Deep Dive into Growth Potential and Market Position

Avadel Pharmaceuticals plc (NASDAQ: AVDL), an Ireland-based biopharmaceutical company, has been capturing investor attention with its promising product pipeline and impressive revenue growth. Specializing in the healthcare sector, particularly in..

Simulations Plus, Inc. (SLP) Stock Analysis: Exploring a 110% Potential Upside Amid Market Volatility

Simulations Plus, Inc. (NASDAQ: SLP), a notable player in the Health Information Services industry, has caught the attention of investors with a striking potential upside of 110.83%. As the company..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds